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In recent years a gradual shift in the definition of Parkinson’s disease (PD) has
been established, from a classical akinetic-rigid movement disorder to a multi-system
neurodegenerative disease. While the pathophysiology of PD is complex and goes much
beyond the nigro-striatal degeneration, the striatum has been shown to be responsible
for many cognitive functions. Patients with PD develop impairments in multiple cognitive
domains and the PD model is probably the most extensively studied regarding striatum
dysfunction and its influence on cognition. Up to 40% of PD patients present cognitive
impairment even in the early stages of disease development. Thus, understanding the
key patterns of striatum and connecting regions’ influence on cognition will help develop
more specific approaches to alleviate cognitive impairment and slow down its decline.
This review focuses on the contribution of neuroimaging studies in understanding how
striatum impairment affects cognition in PD.
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Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects up to 2% of
individuals aged 65 years and older (Rijk et al., 1997) and has an incidence of 14 per 100,000
individuals (Hirtz et al., 2007). In people over 70 years the incidence is much higher—160 per
100,000 individuals (Hirtz et al., 2007), and affects nearly 10% of people older than 80 years (von
Campenhausen et al., 2005). Furthermore, the prevalence of PD is expected to double by 2030
(Dorsey et al., 2007). While PD is associated with a complex pathophysiology that can potentially
affect most of the brain, the motor cardinal symptoms of PD are largely due to degeneration of
dopamine (DA) neurons in the substantia nigra pars compacta (Albin et al., 1989). This pattern of
neurodegeneration starts from dorsal striatum and extends to more ventral parts of the striatum as
the disease progresses (Kish et al., 1988).
Since the second part of the 1980’s it is becoming increasingly clear that cognitive deficits can
be present even at the early stages of PD (Taylor et al., 1986; Taylor and Saint-Cyr, 1995; Dubois
and Pillon, 1996). Initial investigations in mild to moderately affected PD patients emphasized
deficits in executive functions (e.g., planning and set-shifting), which resemble those found in
patients with frontal lobe damage (Taylor et al., 1986; Owen et al., 1990, 1992). These are consistent
with the fronto-striatal dysfunction occurring in PD reported by our group and many others.
However, non-frontal cognitive deficits including visuospatial and language function difficulties
are also recognized in early-PD patients and at various stages of disease progression. In the context
of this review we concentrate on the cognitive deficits that are most likely to originate from the
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fronto-striatal deficits. Indeed, striatal dysfunction in the context
of cognitive deficits in PD is likely the most extensively studied
amongst neurological and mental disorders affecting striatal
functions.
Individuals who meet criteria for mild cognitive impairment
(MCI) exhibit measurable cognitive deficits but those deficits are
not severe enough to interfere significantly with daily life, nor
reach criteria for dementia. MCI in PD patients can be identified
using the MDS Task Force criteria (Litvan et al., 2012) and can
be found in the early stages of the disease with up to 65% of
patients at 1 standard deviation below normative values and in
up to 42% of PD patients at 1.5 standard deviation (Aarsland and
Kurz, 2010; Yarnall et al., 2014). Furthermore, PD patients with
MCI have a higher risk of developing dementia compared with
patients who do not have MCI (Emre et al., 2007; Kehagia et al.,
2010).
Changes in dopaminergic availability are known to greatly
affect fronto-striatal function in PD and to affect cognitive
processes (Cools, 2006). Furthermore, dopaminergic therapy
aimed at the motor symptoms of PD is likely to have an
influence on cognition in PD. In this review we focus on how
striatum and related dopamine dysfunction can affect cognition
in PD and how dopaminergic medication can modulate those
functions.
Striatum Organization
In humans, striatum is attributed to a complex consisting of the
caudate nucleus and putamen (dorsal striatum) as well as the
most ventral part of the caudate nucleus, the ventral part of the
putamen and the nucleus accumbens (ventral striatum) (Grahn
et al., 2009). The striatum connections are organized into direct
and indirect pathways which are based on the striatal output
projections (Figure 1) (Albin et al., 1989). The nigral neurons
project via the nigrostriatal pathway to the striatum (Samii et al.,
2004) and provide dopamine (DA), which reinforces cortically
initiated activation of a particular basal ganglia-thalamo-cortical
circuit. This is achieved by facilitating conduction through the
circuit’s direct pathway, which has a net excitatory effect on
the thalamus, and suppressing conduction through the indirect
pathway, which has a net inhibitory effect on the thalamus
(Alexander and Crutcher, 1990).
The direct pathway consists of neurons that predominantly
express D1 DA receptors, substance P and dynorphin (Haber
and Nauta, 1983; Gerfen et al., 1990; Steiner and Gerfen,
1999). They project from the striatum to the internal segment
of the globus pallidus (GPi) and to substantia nigra pars
reticulata (SNr), eliciting a phasic inhibition of the GPi/SNr
and promoting desired movements (Alexander et al., 1986). The
indirect pathway on the other hand, is comprised of striatal
neurons that express predominantly D2 receptors (Gerfen et al.,
1990), met-enkephalin and neurotensin (Haber and Nauta, 1983;
Steiner and Gerfen, 1999). These neurons project to external
portion of the globus pallidus (GPe) and the subthalamic nucleus
(STN). Since GPe tonically inhibits the SNr, activation of the
indirect pathway performs an inhibition of the GPe and a
disinhibition of the SNr resulting in increased inhibitory activity
of the SNr over the thalamus and thus exerting an inhibition
or termination of the movement (Alexander et al., 1986). DA is
a modulatory neurotransmitter and mediates synaptic plasticity
both morphologically (Li et al., 2004) and electrophysiologically
(Calabresi et al., 1992; Reynolds et al., 2001). The phasic
activation of DA-ergic neurons exert a net excitatory effect on
the direct pathway and an inhibitory effect on the indirect
pathway (Delong and Wichmann, 2007), thus facilitating or
inhibiting the functions that depend on striatum activity—
movements, learning, working memory, attention, and other.
The hyperdirect pathway originates from the axon collaterals of
pyramidal tract neurons and project to the STN, thus it receives
and displays activity directly related to movement (Giuffrida
et al., 1985). This path is faster than the direct and indirect
pathways and it exerts a powerful excitatory effects on the STN
further activating GPi neurons and resulting in the inhibition
of large areas of the thalamus and cortex that are related to the
selected movements and or competing programs (Nambu et al.,
2002).
Striatum connectivity with the cortex has been initially
studied in monkeys and later on using magnetic resonance
diffusion tensor imaging in humans, in vivo (Lehéricy et al.,
2004). The head of the caudate and the rostral putamen were
shown to be connected primarily to the frontal lobe (medial,
ventral, dorsolateral prefrontal cortex (PFC), frontal pole,
pre-supplementary motor area); the posterior putamen revealed
anatomical connectivity with posterior supplementary motor
area, motor and sensory areas, while the ventral striatum
was connected to orbitomedial frontal cortex, temporal pole,
amygdala, and hippocampus (Lehéricy et al., 2004). This
connectivity pattern is in line with previously described
frontostriatal circuits which were segregated into “motor”
(supplementary motor area → putamen), “limbic” (anterior
cingulate → nucleus accumbens), and “associative” domains,
specifically the oculomotor loop (frontal eye fields → caudate
nucleus), the dorsolateral circuit (dorsolateral prefrontal
cortex → dorsolateral caudate nucleus), and ventral orbital
loop (orbitofrontal cortex → ventromedial caudate nucleus)
(Alexander et al., 1986, 1989).
In PD, the loss of DA-ergic inputs from substantia nigra
pars compacta (SNc) leads to an enhanced cholinergic signaling
that in turn produces disinhibition of D2-receptor-containing
striatum neurons. Both the glutamatergic inputs from the cortex
to the striatum and from the STN to the output nuclei are
significantly enhanced while the GABA-ergic inputs from the
striatum and the external segment of the pallidum to the
output nuclei become impaired. This imbalance leads to an
increased inhibitory GABA-ergic output to the thalamus and to
decreased glutamatergic thalamocortical feedback, which results
in hypokinetic motor symptoms as well as hypoactivity in
the cognitive functions, as it has been suggested previously
(e.g., Owen, 2004). Specifically the impairment is attributed to
those cognitive functions that involve the striatum—memory,
visuospatial function, attention and working memory, executive
decision, language, emotions. Previous pathological (Rinne
et al., 1989; Paulus and Jellinger, 1991) and positron emission
tomography studies confirmed a correlation between caudate DA
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FIGURE 1 | Model of the basal ganglia connectivity in healthy (A) and in early Parkinson’s disease (B) [Adapted after Kalivas and Nakamura (1999),
Dudel et al. (2002), Nambu et al. (2002), Gubellini et al. (2009) and Cools (2006)]. Open and filled arrows represent excitatory glutamatergic (glu) and inhibitory
gabaergic (GABA) projections. PMC, Premotor cortex; SMA, supplementary motor area; DLPFC, dorsolateral prefrontal cortex; FEF, frontal eye fields; VLPFC,
ventrolateral prefrontal cortex; ACC, anterior cingulate cortex; OFC, orbitofrontal cortex; VTA, ventral tegmental area; SNc, substantia nigra pars compacta; SNr,
substantia nigra pars reticulata; NAcc, nucleus accumbens; GPe, external segment of the globus pallidus; GPi, internal segment of the globus pallidus; STR, striatum;
STN, subthalamic nucleus; THA, thalamus; DA, dopamine; SP, Substance P; D1, D1 class DA receptors; D2, D2 class DA receptors.
loss and neuropsychological performance in PD patients (Marié
et al., 1999; Brück et al., 2001) suggesting a preferential role for
this system in cognitive impairment (Ito et al., 2002).
In patients with PD, cognitive impairment is frequently
observed, especially with respect to executive functions
(Cools, 2006), which are cognitive mechanisms through
which performance is optimized in situations requiring the
simultaneous operation of different processes (Morris et al.,
1990). Executive control is especially active when the action
or response is novel or complex (Norman and Shallice, 1986)
such as pursuing a long-term goal requiring the completion
of multiple intermediate sub-goals and behavior. Executive
functioning refers to (1) switching attention between different
processes (attentional set-shifting); (2) directing attention
to a relevant stimulus and inhibiting the irrelevant stimuli
(goal-directed action); (3) coding and checking the contents of
memory storage (working memory) and (4) concept formation
and planning strategies (Cools, 2006).
Striatal Impairment in Attentional
Set-shifting
Attentional set-shifting is probably the most widely studied
executive deficit in PD (Cools et al., 1984; Downes et al., 1989;
Owen et al., 1992; Van Spaendonck et al., 1996; Monchi et al.,
2004) but it is also impaired in patients with prefrontal cortex
(PFC) lesions (Gotham et al., 1988; Cools et al., 2001b). The
Wisconsin Card Sorting Task (WCST) is the most commonly
used test to assess set-shifting in humans (Milner, 1963; Nelson,
1976) and involves matching test cards to one of four reference
cards according to three possible classification rules. Participants
must use feedback in order to select the correct rule, as
it is not explicitly given. After a fixed number of correct
matches, the rule is changed without notice and participants
must switch to a new rule for classification, constituting a
set-shift. Using an event-related fMRI protocol in healthy
controls, we showed the implication of two cortico-striatal
loops during different WCST stages. When planning a set-
shift, the ventrolateral PFC (VLPFC), the caudate nucleus, and
the thalamus were significantly activated, while the execution
of the set-shift solicited the posterior PFC and the putamen
(Monchi et al., 2001). The same protocol was subsequently
used in early-stage PD patients (following overnight DA-ergic
medication removal) and matched controls (Monchi et al.,
2004). The results reduced activation in the PD group in the
VLPFC when receiving negative feedback and the posterior
prefrontal cortex when matching following negative feedback.
Activity in these areas specifically correlated with the striatum
in controls. By contrast, greater activation was found in the PD
group in areas that were not co-activated with the striatum in
controls. These results suggest that both nigrostriatal dopamine
depletion and intra-cortical dopamine deficiency may play a
role in cognitive deficits in PD, depending on the involvement
of the striatum in the task at hand (see below). Furthermore,
using the same protocol in early PD patients divided into two
groups based on the presence of MCI, PD patients without
mild cognitive impairment (PD-non-MCI) “off” medication,
revealed patterns of activation similar to healthy individuals from
our previous studies when planning a set-shift (Monchi et al.,
2004, 2007; Jubault et al., 2009) with significant activation in
the VLPFC and caudate nucleus. In contrast, PD patients who
had mild cognitive impairment (PD-MCI) had no significant
activation in these regions (Nagano-Saito et al., 2014). Also,
when matching following the set-shift, the PD-non-MCI group
revealed significant activity in the premotor cortex but not
the putamen resembling previous PD “ON” medication results
(Jubault et al., 2009). Similar results have been observed in PD-
MCI and PD-non-MCI patients while performing a working
memory task (Ekman et al., 2012; Monchi and Stoessl, 2012).
The finding of striatal activation in the WCST is consistent with
the possibility that the basal ganglia are involved in selecting the
relevant action among competing motor responses (Mink and
Thach, 1993).
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Striatal Impairment in Goal-directed Action
and Planning Strategies
The Tower of London (Shallice, 1982) has often been used to
analyze the failure of goal-directed action and planning strategies
in PD. During this test patients are required to move a set of
three colored balls around in “pockets” or “socks” to match
a goal arrangement presented at the top of the screen (Owen
et al., 1990). This task involves several stages (1) evaluation of
the overall situation—understanding the differences between the
initial state and the goal; (2) defining the sequence of moves
that are necessary to achieve the goal; and (3) executing the
correct solution. This task has been shown to recruit the caudate
nucleus and the dorsolateral prefrontal cortex (Owen et al.,
1996). In healthy controls, when the difficulty of the problem
was increased, there was an increase in caudate nucleus activity
(Owen et al., 1996; Dagher et al., 1999), while increasing the
number of moves resulted in increased activity in the putamen
(Dagher et al., 1999). PD patients at the early stage of the disease
spent more time on planning the strategy than the controls
(Owen et al., 1992). Furthermore, according to a functional
neuroimaging study, the right caudate nucleus activity has been
reported to be impaired in patients with mild PD compared
with healthy controls when performing the task (Dagher et al.,
2001). Interestingly, an eye-gaze behavior study has shown that
PD patients seemed to fail to attend appropriately to the goals of
the task (Hodgson et al., 2002).
It is clear that striatum impairment in PD leads to impaired
goal-directed action and planning strategies. However, there may
be two different reasons for this: (1) the inability to identify
and maintain relevant goal information, or (2) bradyphrenia,
i.e., slower thinking and an increase in the time taken to solve
problems while the process of problem solving is preserved.
Additionally, problem solving is likely not uniquely a striatal
function but also a frontal one. Previous studies reported that
impaired problem solving was present in patients with frontal
lobe lesions (Owen et al., 1990). Indeed, it has been reported
that abnormal striatal activation in PD was accompanied by
a performance deficit similar to the one observed in patients
with frontal lobe damage (Owen et al., 1993), but there were
no abnormalities in the regional cerebral blood flow in the
prefrontal cortex (Dagher et al., 2001). Additionally, patients
with frontal lobe damage did not reveal longer thinking times
during Tower of London task but they required more moves
to reach the goal (Owen et al., 1990). This would suggest that
striatum is responsible for the goal-directed deficit. Furthermore,
according to some reports, medicated PD patients were shown
to be impaired in the amount of time spent thinking about the
solution (planning) (Owen et al., 1992), while another Tower
of London study reported that even if PD patients directed
their eyes toward the workspace, during planning like healthy
controls, they divided their attention equally between the goals
and the workspace. This suggests that the planning deficit in
PD is due to abnormal encoding and maintenance of current
goals (Hodgson et al., 2002). In conclusion to this section, it
seems that the striatum is responsible for efficient goal-directed
actions (encoding andmaintaining the goals), but that the striatal
dysfunction and the increased inhibitory GABA-ergic output to
the thalamus that is present in PD, lead to both to an increased
amount of time spent thinking and planning as well as with
respect to goal-directed actions.
Striatal Impairment in Working Memory
and Decision-making
Dopamine (DA) innervation to the prefrontal cortex and the
striatum is critical for normal decision-making and working
memory function both at the cellular and behavioral levels
(Goldman-Rakic, 1995; Williams and Goldman-Rakic, 1995).
Working memory is important for the ability to hold and
manipulate information when involved in problem solving and
decision making (Frank et al., 2007). Specifically, D1-receptor
activation in the striatum (the direct pathway) has been shown
to stabilize neuronal ensembles with high activity in the PFC,
and this was suggested to be a method of maintaining the
information within working memory (Durstewitz and Seamans,
2006). On the other hand, D2-receptors (the indirect pathway)
appears to destabilize neuronal ensembles and makes them more
susceptible to neuronal input, a state that has been considered
as updating the information in working memory (Durstewitz
et al., 2000). Working memory performance is also compromised
in both PD patients and those with frontal lobe lesions, even
if the reasons of impairment are different. One study showed
that both groups of patients are impaired on a test that requires
the selection and sequencing between a series of sub-goals
(Owen et al., 1990, 1992). Participants were required to search
for hidden “tokens” through boxes and to avoid the boxes
that previously were associated with reward (between search)
and to avoid returning to boxes that were previously opened
and shown to be empty (within search) (Owen et al., 1990).
Both groups of patients—PD and frontal lobe-lesioned—showed
“between search” errors when compared with healthy controls
(Owen et al., 1992), but PD patients did not have significant
“within search errors,” unlike frontal lobe-lesioned ones (Owen
et al., 1996). Other studies also confirmed that working memory
dysfunctions was associated with reduced activity (Lewis et al.,
2003) and abnormal blood flow (Owen et al., 1998) in the
caudate nucleus in PD patients who were executively impaired.
Additionally, structural studies revealed that larger caudate size
in the individuals deemed at ultra-high risk of psychosis was
associated with greater errors on a spatial working memory task
(Hannan et al., 2010). These results underline that frontal lobe
is associated with performing the search and adopting strategies
and organization with working memory (because the frontal lobe
is likely less impaired in early PD) while the caudate nucleus
becomes involved when there is a necessity of self-generated
novel actions that would alternate effectively between important
sub-goals and consequently modifies the behavior.
Striatal Impairment in Procedural Learning
Learning associations between stimuli and responses or
categories is an important ability across species (Wise and
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Murray, 2000), and the striatum, particularly the caudate
nucleus, plays a key role in such learning (Seger and Cincotta,
2005). The cortico-striatal circuitry has been emphasized to
have a critical role in learning, and specifically in supporting
the “procedural” learning system (Eichenbaum and Cohen,
2001; Shohamy et al., 2004). In fact, studies revealed that PD
patients were slower during learning of an associative task,
but they were unimpaired in the process of transferring the
information, while patients with hippocampal atrophy showed
the opposite pattern—good initial learning and impaired ability
to transfer when familiar stimuli were presented in novel
recombination (Swainson et al., 2000; Myers et al., 2003). Further
investigations using a behavioral task in which participants
viewed arbitrary visual patterns and used them to predict
one of two possible outcomes, revealed that caudate nucleus
contributes to learning in two distinct ways. Activity associated
with successful classification learning (correct categorization)
is concentrated to the body and tail of the caudate nucleus,
while activity associated with feedback processing (the result
of incorrect categorization) is concentrated to the head of the
caudate nucleus (Seger and Cincotta, 2005). Patients with early
PDwere shown to bemuchmore impaired at rule-based category
learning than at information classification learning (Ashby et al.,
2003). This is in line with the progressive neurodegeneration
pattern in PD (Kish et al., 1988) with an increased rate in the
head of the caudate nucleus—hence worse functioning, and a
lower extent of neurodegeneration in the caudate nucleus tail.
Interrelation between Striatum and
Prefrontal Cortex
Executive functions are widely associated with the frontal lobe,
in particular with the dorsolateral prefrontal cortex (DLPFC),
which is involved in certain aspects of working memory
(Petrides, 2000) and cognitive flexibility (Milner, 1963; Goldman-
Rakic, 1987). Specifically, anatomical studies showed that the
most rostrodorsal extent of the caudate head is connected
with the DLPFC (Yeterian and Pandya, 1991) while PET
studies demonstrated increased PFC activation in PD patients
performing tests of executive function (Owen et al., 1998; Dagher
et al., 2001). From this point of view, in PD patients one would
expect diminished activity in the DLPFC as well, considering that
within the caudate nucleus DA depletion is greatest in the caudate
head (to a maximum of about 90%). Nevertheless, our previous
studies showed that increase and decrease in PFC activity in
patients with PD is related to whether the striatum is necessary
for the task or not (Monchi et al., 2004, 2007, 2010). Specifically,
we revealed a decrease in PFC activity (hypoactivation) of
patients with PD off medication compared with healthy controls,
for tasks that recruit the striatum in healthy controls (i.e.,
planning a set-shift). In contrast, when performing tasks that do
not require the striatum (i.e., task execution without changing
the rule) in healthy controls, patients with PD showed significant
prefrontal and parietal increases in activity—hyperactivation—
usually unrelated to the task (Monchi et al., 2007). Previous
investigations in PD patients “on” medication compared to those
in the “off” state suggested that DA level accounted for the
greater PFC activation in PD “on” medication (Cools et al., 2002;
Mattay et al., 2002). These hyperactivations can be explained by
an increase of DA support through the mesocortical projections,
by which neurons from the ventral tegmental area (VTA) and
the medial SNc project to the frontal lobe (Tzschentke, 2001;
Grahn et al., 2009). Unlike the nigrostriatal DA-ergic system,
which refers to the SNc DA [and which has been termed also as
mesostriatal, because it refers to the SNc-VTA complex (Lindvall
et al., 1977)], the VTA DA-ergic neurons project to the PFC
(mesocortical pathway) and to the ventral striatum (mesolimbic
pathway) (Björklund and Dunnett, 2007). In fact, it has been
shown that cortical DA has a critical role in executive functions
and high-level cognition (Murphy et al., 1996; Watanabe et al.,
1997). Since DA neurons in the substantia nigra degenerate much
earlier in the disease than neurons in the VTA (Agid et al.,
1987a,b; Kish et al., 1988), activity during cognitive tasks of the
cortical regions could be modulated by DA replacement through
the mesocortical pathway (Tzschentke, 2001; Grahn et al., 2009).
On the other hand, our studies revealed that levodopa
showed no effect on the activity of the cognitive fronto-
striatal loop which included the DLPFC and the caudate
nucleus, despite a significant effect on the activity of motor
regions (Jubault et al., 2009; Martinu et al., 2012). A possible
explanation for this increased activity in the DLPFCmight be that
mesocortical projections innervate predominantly the medial
PFC, the infralimbic and prelimbic subareas (Tzschentke, 2001),
hence PFC reveals a compensatory pattern not associated with
DA concentration. This would suggest that even if in healthy
controls the frontal cortex might not normally get involved in
certain cognitive functions of the striatum, it becomes engaged
in order to maintain a specific activity, as suggested previously
(Samuel et al., 1997). Another explanation is that mesocortical
projections have a diminished responsiveness to DA agonists and
antagonists (Bannon and Roth, 1983), hence the absence of any
effect on the activity of the cognitive fronto-striatal loop in our
study. Nevertheless, a recent fMRI study in de-novo (untreated)
PD patients during a set-shifting task, indicated that some of
these frontal and parietal hyper-activation may be compensatory
(Gerrits et al., 2015). It is likely that these hyperactivity patterns
can represent both a mesocortical imbalance and compensation,
depending on various factors, including the exact nature of the
task, the advancement of the disease and the amount and type of
dopamine medication being taken.
Ventral Striatum Impairment and Cognitive
Changes
Ventral striatum includes nucleus accumbens, rostral/ventral
caudate nucleus and putamen. These regions are connected with
orbital, medial (Haber et al., 1995) and ventral PFC (Yeterian
and Pandya, 1991) forming the limbic loop, and are involved
in emotional processing, motivational and stereotyped behavior,
attention deficit disorder, hyperactivity disorder, compulsive
disorders, Tourette’s syndrome (Grabli et al., 2004), and reversal
of stimulus reward associations (Nauta, 1971; Rolls, 2000).
Furthermore, the nucleus accumbens is essential in integrating
cortical and limbic information into goal-directed behavior
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(Pennartz et al., 1994). Several studies reported that in the earlier
stages of PD development, DA depletion is restricted to the
putamen and the dorsal caudate nucleus, while in the later stages
DA depletion progresses to the more ventral parts of the striatum
and the mesocortico-limbic DA-ergic system (Rosvold, 1972;
Kish et al., 1988; Swainson et al., 2000; Cools et al., 2001a).
This uneven pattern of striatal DA loss has been confirmed by
postmortem neurochemical analysis in patients with PD (Kish
et al., 1988). The different spatiotemporal progression of DA
depletion within the striatum and the terminal distribution
of its cortical afferents may be the best explanation for the
evolving pattern of cognitive impairments observed in PD
patients (Gotham et al., 1988). Specifically, we previously showed
that PD patients who had MCI presented a higher rate of volume
diminishment over time in the nucleus accumbens and a higher
rate of cortical thinning in comparison to PD patients without
MCI and to healthy controls (Hanganu et al., 2014).
On the other hand, the different level of DA depletion
leaves room for DA overdosage due to DA-ergic treatment.
The “over-dose” hypothesis has been discussed by many studies
previously (Gotham et al., 1988; Swainson et al., 2000; Cools
et al., 2001a) and it states that levodopa doses necessary to
remedy the DA lack in severely depleted brain areas, such as
the putamen, would detrimentally “over-dose” relatively intact
brain areas in early PD, such as the ventral striatum and
its connections to the orbital PFC. In fact, previous studies
reported the impairment of ventral striatum in early disease
with respect to DA therapy. Learning was most commonly
impaired in PD patients tested on DA replacement therapy.
Cognitive tasks such as probabilistic reversal learning, that
challenges the ventral frontostriatal circuit (ventral PFC and
ventral striatum), revealed decreased performance in PD patients
with DA-ergic treatment, although PD patients off medication
showed similar performance to controls (Cools et al., 2001a;
Torta et al., 2009; Jahanshahi et al., 2010). Other studies in PD
reported impaired learning of discrimination tasks (Shohamy
et al., 2006) and sequences associated with DA-ergic medication
usage (Feigin et al., 2003; Seo et al., 2010; Tremblay et al., 2010).
DA treatment in PD patients also yielded reduced facilitation for
consecutive, consistent stimulus–stimulus pairings in a selection
task compared to normal implicit learning (MacDonald et al.,
2011). Furthermore, once a stimulus-reward association was
learned, reversing probabilities of stimulus-reward associations
was also impaired in PD patients on medication (Swainson et al.,
2000; Cools et al., 2001a, 2006; Graef et al., 2010; MacDonald
et al., 2011). Time estimation was also affected. Increased
response time was reported in a simple reaction task in PD
patients after administration of DA in comparison to PD patients
off medication and healthy controls (Müller et al., 2001).
The nucleus accumbens is also thought to be involved
in inhibitory control processes (Christakou et al., 2004) and
increased impulsive choice (Cardinal et al., 2001). In the case
of PD patients, impulsive betting was noted after DA treatment,
despite appropriate and deliberate decision making (Cools
et al., 2003; Torta et al., 2009). Other studies also reported an
increased number of impulse control disorders in PD patients
on medication, such as pathological gambling, compulsive sexual
behavior, compulsive buying, and binge eating (Ray and Strafella,
2010; Weintraub et al., 2010).
In line with the “overdose” hypothesis, studies reported
an improvement of functions associated with ventral striatum
during “off” state. Specifically, improvements were shown in
the learning to avoid choices that lead to negative outcomes
in comparison to learning from positive outcomes (Frank
et al., 2004). Other studies reported improvement in associative
conditional learning (Gotham et al., 1988) and probabilistic
reversal learning (Swainson et al., 2000; Cools et al., 2001a). These
functions have been associated with the ventral striatum and the
ventral PFC including the orbitofrontal cortex (Dias et al., 1996;
Passingham et al., 2000; Cools et al., 2001a). On the other hand,
levodopa withdrawal has been shown to impair PD patients in
verbal fluency (Gotham et al., 1988), set-shifting tasks (Cools
et al., 2001a), spatial recognition memory task (Swainson et al.,
2000), and in tasks requiring trial and error (Frank et al., 2004),
functions that are associated especially with the dorsal caudate
and DLPFC (Owen et al., 1990).
The nucleus accumbens has also been heavily associated with
reward processing (Schultz et al., 2000). Indeed various studies
have investigated the effect of dopamine replacement therapy in
PD in the context of stimulus-reward learning. It was reported
that once a stimulus-reward association was learned, reversing
probabilities of stimulus-reward associations was impaired in
PD patients on dopaminergic medication (Swainson et al., 2000;
Cools et al., 2001a, 2006; Graef et al., 2010; MacDonald et al.,
2011). A two-fold study by MacDonald et al. (2011) used a
simple selection task to elucidate functions mediated by the
ventral and dorsal striatum respectively with fMRI in healthy
individuals, and to better understand the cognitive effects of
dopamine replacement in PD testing them behaviourally with
the task once ON their usual dose of DA-ergic medication and
once following overnight withdrawal. In healthy individuals, the
congruent condition that involved consistent stimulus–stimulus
associations across two consecutive events, without reward or
feedback being provided, solicited significant ventral striatum
activation, while the incongruent condition that involved
conflicting relationships across two consecutive events (baring
similarity to set-shifting) solicited significant activation in the
head of the caudate nucleus. In PD patients DA replacement
impaired encoding and facilitation of consistent stimulus–
stimulus relations across trials in the congruent condition relying
on ventral striatum, while it enhanced interference related to
assimilating conflicting influences on selection across trials in
the incongruent condition relying on dorsal striatum. These
studies gave support that impairments specific to the ventral
striatum in PD patients can be explained by the “over-dose”
hypothesis (Gotham et al., 1988; Swainson et al., 2000; Cools
et al., 2001a).
Striatum and Cerebellum Relationship in
PD with Respect to Cognitive Changes
It has been suggested that cerebellum may compensate
for impaired basal ganglia cognitive function (Strick et al.,
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2009; Appel-Cresswell et al., 2010) and several fMRI studies
reported evidence that cerebello-thalamo-cortical loop increases
its activity to compensate for degeneration in the striato-
thalamo-cortical loop to maintain a near-normal motor function
(Glickstein and Stein, 1991). This compensational patterns are
further explained by the presence of two main cerebellum
circuits—the “motor” loop, projecting from the motor and
premotor cortex to the dentate nucleus, and the “prefrontal”
loop, that connects the posterior PFC (Brodmann Area 9/46)
and the dentate nucleus (Kelly and Strick, 2003). The prefrontal
loop has been associated with cognitive functions (Strick et al.,
2009). Furthermore, recent evidence reported direct connections
between striatum and cerebellar circuits (Bostan and Strick,
2010)—a tri-synaptic connection between the GPe and the
dentate nucleus (Hoshi et al., 2005) and a bi-synaptic projection
from the STN to the cerebellar cortex via pontine nuclei
(Bostan et al., 2010). Altogether, this gives strong support that
cerebellum is an organized compartment used for the integration
of non-motor functions such as emotion, working memory, and
language, as suggested previously (Stoodley and Schmahmann,
2009).
In PD patients, it has been argued that cerebellum has a
compensatory role because when patients were off medication
they revealed increased activation in the cerebellum during
externally guided motor tasks, compared with healthy controls
and with PD patients on medication (Rascol et al., 1997;
Cerasa et al., 2006; Yu et al., 2007), as well as during internally
generated movements (Cerasa et al., 2006; Yu et al., 2007).
Furthermore, a negative correlation has been reported between
cerebellum and contralateral putamen in PD patients off
medication, suggesting that cerebellum activity increases in
order to compensate the reduced putamen activation (Yu et al.,
2007). Furthermore, PD patients off medication, when compared
to healthy controls, revealed decreased functional connectivity
in the supplementary motor area, DLPFC and putamen, while
cerebellum, primary motor cortex, and parietal cortex showed
increased connectivity (Ng et al., 2010). Levodopa administration
relatively normalized this connectivity pattern in PD
patients.
It is also worth to note that one of cerebellum functions
regarding cognition, is its timing capacity. Patients with
cerebellar damage have difficulties accurately producing and
perceiving time intervals (Ivry and Keele, 1989) and due to this,
internal cognitive states may no longer be appropriately selected
and sequenced at a fine level, which may exhibit problems with
task-shifting and other forms of executive control (Strick et al.,
2009). Our previous work with set-shifting tasks reported a
decrease in timing activity in the prefrontal regions of patients
with PD off medication compared to healthy controls for tasks
that require the striatum in healthy controls (Monchi et al.,
2007).
On the other hand, several researchers presented contrasting
results. Hosokai and colleagues didn’t find any significant
increase in cerebellar metabolism both in PD-demented and
PD-MCI patients in comparison to PD patients without
MCI (Hosokai et al., 2009). Furthermore, one previous PET
study reported a negative correlation between the cerebellum
metabolism and regional cerebral blood flow both in PD patients
and in healthy controls during procedural memory processes
(Dagher et al., 2001). These results indicate that the cerebellum
does not necessarily compensate for cognitive impairment
of basal ganglia origin. Habas et al. (2009) also questioned
cerebellum’s cognitive functions due to failure of some studies
to find significant cognitive impairment in cerebellar lesion
patients (Helmuth et al., 1997; Thier et al., 1999; Haarmeier
and Thier, 2007). Furthermore, in their reports Glickstein
(2006) and Glickstein et al. (2011) failed to replicate previous
studies reporting cerebellar contribution to cognition in PD
even when using a low threshold. Finally, it has also been
argued that the cerebellum activation in cognition can be subject
to contamination by skeletal or eye movements (Strick et al.,
2009).
In summary, the hypothesis that cerebellar circuits may
compensate for impaired basal ganglia cognitive function in
PD, as suggested previously (Stoodley and Schmahmann, 2009;
Appel-Cresswell et al., 2010), still remains unresolved and further
investigations are necessary.
Conclusion
Striatum impairment in PD is caused initially by a diminished
modulatory effect of DA from the SNc which results in
enhanced GPi activation, increased inhibitory output to the
thalamus and decreased thalamocortical feedback. Such a
dysregulation destabilizes neuronal input, affecting the fronto-
striatal loops, and impairing cognitive function. DA replacement
therapy increases the striatum modulatory function, yet it
also induces an overdose effect on the structures that have
a relatively normal DA level, impairing their functions (e.g.,
ventral striatum) and as the disease continues to progress,
cognitive impairment progresses along. In the initial stages of
PD development PFC maintains a normal cognitive activity,
either due to mesocortical DA sources or due to compensational
patterns, which makes the cognitive impairment profile to
be restricted to the dorsal striatum dysfunction. Nevertheless,
the present DA replacement therapies cannot avoid further
cognitive decline, since it has been shown that up to 75% of
PD patients eventually develop dementia (Aarsland and Kurz,
2010). Furthermore, some studies reported that intellectual
deterioration does not seem to result from dysfunction of DA-
ergic mechanisms (Pillon et al., 1989). Taken together, these
data suggest that cognitive disturbances in PD are related
both to nigrostriatal, mesolimbic, and mesocortical DA-ergic
systems as well as non-striatal and non-dopaminergic origins.
Specifically, abnormalities in other systems have been found
in PD (Agid et al., 1987a)—the cholinergic septo-hippocampal
and innomasto-cortical pathways, the noradrenergic coeruleo-
cortical neurons and the serotoninergic neurons (dorsal raphe
nuclei) (Ruberg and Agid, 1988; Jellinger, 1999). Relationships
between lesions of cholinergic (Sadeh et al., 1982; Bohnen et al.,
2006; Ziabreva et al., 2006) and noradrenergic (Cash et al., 1987;
Delaville et al., 2011; McMillan et al., 2011) systems and cognitive
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impairment in PD patients have been reported previously.
Furthermore, degeneration of cortical neurons or decreases in
cortical peptide concentrations (Agid et al., 1987b) may also
contribute to cognitive impairment in PD. These systems should
also be addressed in order to encircle the whole extent of striatal
and non-striatal cognitive dysfunction in PD.
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